142 related articles for article (PubMed ID: 19759053)
1. Aprepitant-associated ifosfamide neurotoxicity.
Hansen Ho ; Yuen C
J Oncol Pharm Pract; 2010 Jun; 16(2):137-8. PubMed ID: 19759053
[No Abstract] [Full Text] [Related]
2. Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.
Howell JE; Szabatura AH; Hatfield Seung A; Nesbit SA
J Oncol Pharm Pract; 2008 Sep; 14(3):157-62. PubMed ID: 18719071
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors.
Tajino T; Kikuchi S; Yamada H; Takeda A; Konno S
J Orthop Sci; 2010 Jan; 15(1):104-11. PubMed ID: 20151259
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
5. Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Jarkowski A
Am J Health Syst Pharm; 2008 Dec; 65(23):2229-31. PubMed ID: 19020190
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prevention of iphosphamide-induced encephalopathy].
Sunela K; Bärlund M
Duodecim; 2016; 132(4):314-7. PubMed ID: 27017785
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.
Durand JP; Gourmel B; Mir O; Goldwasser F
Ann Oncol; 2007 Apr; 18(4):808-9. PubMed ID: 17389531
[No Abstract] [Full Text] [Related]
8. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
9. Incidence and severity of ifosfamide-induced encephalopathy.
Rieger C; Fiegl M; Tischer J; Ostermann H; Schiel X
Anticancer Drugs; 2004 Apr; 15(4):347-50. PubMed ID: 15057138
[TBL] [Abstract][Full Text] [Related]
10. An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center.
Szabatura AH; Cirrone F; Harris C; McDonnell AM; Feng Y; Voit D; Neuberg D; Butrynski J; Fisher DC
J Oncol Pharm Pract; 2015 Jun; 21(3):188-93. PubMed ID: 24664476
[TBL] [Abstract][Full Text] [Related]
11. Suspected ifosfamide-induced neurotoxicity.
McVay JI; Wood AM
Pharmacotherapy; 1999 Dec; 19(12):1450-5. PubMed ID: 10600096
[TBL] [Abstract][Full Text] [Related]
12. Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review.
Vazirian F; Samadi S; Rahimi H; Sadeghi M; Mohammadpour AH
Cancer Chemother Pharmacol; 2022 Jul; 90(1):1-6. PubMed ID: 35635561
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
[TBL] [Abstract][Full Text] [Related]
14. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide encephalopathy.
Ajithkumar T; Parkinson C; Shamshad F; Murray P
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):108-14. PubMed ID: 17355105
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide neurotoxicity: an atypical presentation with psychiatric manifestations.
Kerdudo C; Orbach D; Sarradet JL; Doz F
Pediatr Blood Cancer; 2006 Jul; 47(1):100-2. PubMed ID: 16261598
[TBL] [Abstract][Full Text] [Related]
17. Important role of thiamine in preventing ifosfamide-induced encephalopathy.
Lombardi G; Zustovich F; Nicoletto MO; Donach M; Pastorelli D
J Oncol Pharm Pract; 2010 Jun; 16(2):135-6. PubMed ID: 19692431
[No Abstract] [Full Text] [Related]
18. Severe ifosfamide-induced neurotoxicity: a case report.
Ramos Linares S; Breña Atienza J; Cháfer Rudilla M; Ríos Rull P; Cabello Rodríguez A; Merino Alonso J
Pharm World Sci; 2010 Apr; 32(2):109-11. PubMed ID: 20033290
[TBL] [Abstract][Full Text] [Related]
19. [High-dose ifosfamide in the treatment of patients with soft tissue sarcoma].
Tiuliandin SA; Liubimova NV; Sidorova NI; Averinova SG; Kashkadaeva AV; Romanova LF; Shiriaev SV; Garin AM
Vopr Onkol; 1996; 42(6):19-22. PubMed ID: 9123896
[TBL] [Abstract][Full Text] [Related]
20. Role of thiamine in managing ifosfamide-induced encephalopathy.
Hamadani M; Awan F
J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]